Associations between sex steroid hormones and female malignancies
Open Access
- 21 August 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (34) , e50317
Abstract
Sex steroid hormones, including estradiol (E2), estrone (E1), follicle-stimulating hormone (FSH), and luteinizing hormone (LH), have been implicated in the development of female malignancies (FMs), yet their independent and combined effects remain unclear. We conducted a cross-sectional analysis using data from the National Health and Nutrition Examination Survey (NHANES). Weighted logistic regression, restricted cubic spline modeling, and chi-square trend tests were applied to evaluate dose-response associations. Machine learning algorithms, including Bayesian Kernel Machine Regression, Extreme Gradient Boosting, Shapley Additive Explanations, Least Absolute Shrinkage and Selection Operator regression, and Random Forest, were used to explore nonlinear relationships and assess variable importance in an exploratory manner. Sensitivity analyses confirmed the robustness of the findings. A total of 2108 participants were included. Higher FSH and LH levels were associated with increased odds of FMs, whereas higher E2 levels were associated with lower odds. In exploratory machine learning analyses, FSH and E1 were consistently ranked as important predictors of FMs. In this cross-sectional analysis, LH and FSH were associated with increased odds of FM, while higher E2 levels were inversely associated with malignancy risk. Exploratory machine learning analyses highlighted additional nonlinear patterns involving E2 and E1.Keywords
This publication has 32 references indexed in Scilit:
- The association of endogenous sex hormones with endometrial cancer risk: A systematic review and meta-analysisEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2025
- Sex hormones and immune regulation in ovarian cancerDiscover Oncology, 2024
- Estrogens and breast cancerAnnals of Oncology, 2024
- Follicle-stimulating hormoneTrends in Endocrinology & Metabolism, 2024
- A cross-sectional study of the association between heavy metals and pan-cancers associated with sex hormones in NHANES 1999–2018Environmental Science and Pollution Research, 2023
- Follicle-stimulating hormone (and luteinizing hormone) in ovarian stimulation: Does the dose matter for cycle success?Fertility and Sterility, 2022
- Rerouting of follicle-stimulating hormone secretion and gonadal functionFertility and Sterility, 2022
- Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasisCell Reports, 2022
- Influence of breast cancer risk factors and intramammary biotransformation on estrogen homeostasis in the human breastArchives of Toxicology, 2020
- Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-upBreast Cancer Research and Treatment, 2013